Newaz M A, Nawal N N, Rohaizan C H, Muslim N, Gapor A
Faculty of Medicine, International Islamic University, Malaysia, Kuantan.
Am J Hypertens. 1999 Aug;12(8 Pt 1):839-44. doi: 10.1016/s0895-7061(99)00022-9.
Antioxidant protection provided by different doses of alpha-tocopherol was compared by determining nitric oxide synthase (NOS) activity in blood vessels of spontaneously hypertensive rats (SHR) treated with alpha-tocopherol. SHR were divided into four groups namely hypertensive control (C), treatment with 17 mg of alpha-tocopherol/kg diet (alpha1), 34 mg of alpha-tocopherol/kg diet (alpha2), and 170 mg of alpha-tocopherol/kg diet (alpha3). Wister Kyoto (WKY) rats were used as normal control (N). Blood pressure were recorded from the tail by physiography every other night for the duration of the study period of 3 months. At the end of the trial, animals were sacrificed. The NOS activity in blood vessels was measured by [3H]arginine radioactive assay and the nitrite concentration in plasma by spectrophotometry at wavelength 554 nm using Greiss reagent. Analysis of data was done using Student's t test and Pearson's correlation. The computer program Statistica was used for all analysis. Results of our study showed that for all the three alpha-tocopherol-treated groups, blood pressure was significantly (P < .001) reduced compared to the hypertensive control and maximum reduction of blood pressure was shown by the dosage of 34 mg of alpha-tocopherol/kg diet (C: 209.56 +/- 8.47 mm Hg; alpha2: 128.83 +/- 17.13 mm Hg). Also, NOS activity in blood vessels of SHR was significantly lower than WKY rats (N: 1.54 +/- 0.26 pmol/mg protein, C: 0.87 +/- 0.23 pmol/mg protein; P < .001). Although alpha-tocopherol in doses of alpha1, alpha2, and alpha3 increased the NOS activity in blood vessels, after treatment only that of alpha2 showed a statistical significance (P < .01). Plasma nitrite concentration was significantly reduced in SHR compared to normal WKY rats (N: 54.62 +/- 2.96 mol/mL, C: 26.24 +/- 2.14 mol/mL; P < .001) and accordingly all three groups showed significant improvement in their respective nitrite level (P < .001). For all groups, NOS activity and nitrite level showed negative correlation with blood pressure. It was significant for NOS activity in hypertensive control (r = -0.735, P = .038), alpha1 (r = -0.833, P = .001), and alpha2 (r = -0.899, P = .000) groups. For plasma nitrite, significant correlation was observed only in group alpha1 (r = -0.673, P = .016) and alpha2 (r = -0.643, P = .024). Only the alpha2 group showed significant positive correlation (r = 0.777, P = .003) between NOS activity and nitrite level. In conclusion it was found that compared to WKY rats, SHR have lower NOS activity in blood vessels, which upon treatment with antioxidant alpha-tocopherol increased the NOS activity and concomitantly reduced the blood pressure. There was correlation of lipid peroxide in blood vessels with NOS and nitric oxide, which implies that free radicals may be involved in the pathogenesis of hypertension.
通过测定用α-生育酚治疗的自发性高血压大鼠(SHR)血管中的一氧化氮合酶(NOS)活性,比较了不同剂量α-生育酚提供的抗氧化保护作用。SHR被分为四组,即高血压对照组(C)、17mgα-生育酚/千克饮食治疗组(α1)、34mgα-生育酚/千克饮食治疗组(α2)和170mgα-生育酚/千克饮食治疗组(α3)。Wister Kyoto(WKY)大鼠用作正常对照组(N)。在为期3个月的研究期间,每隔一晚通过生理记录仪从大鼠尾部记录血压。试验结束时,处死动物。通过[3H]精氨酸放射性测定法测量血管中的NOS活性,并使用格里斯试剂通过分光光度法在554nm波长下测量血浆中的亚硝酸盐浓度。使用学生t检验和皮尔逊相关性进行数据分析。所有分析均使用计算机程序Statistica。我们的研究结果表明,与高血压对照组相比,所有三个α-生育酚治疗组的血压均显著降低(P <.001),且34mgα-生育酚/千克饮食剂量组的血压降低幅度最大(C组:209.56±8.47mmHg;α2组:128.83±17.13mmHg)。此外,SHR血管中的NOS活性显著低于WKY大鼠(N组:1.54±0.26pmol/mg蛋白质,C组:0.87±0.23pmol/mg蛋白质;P <.001)。尽管α1、α2和α3剂量的α-生育酚增加了血管中的NOS活性,但治疗后只有α2组具有统计学意义(P <.01)。与正常WKY大鼠相比,SHR血浆中的亚硝酸盐浓度显著降低(N组:54.62±2.96μmol/mL,C组:26.24±2.14μmol/mL;P <.001),因此所有三个组的各自亚硝酸盐水平均有显著改善(P <.001)。对于所有组,NOS活性和亚硝酸盐水平与血压呈负相关。在高血压对照组(r = -0.735,P =.038)、α1组(r = -0.833,P =.001)和α2组(r = -0.899,P =.000)中,NOS活性的相关性显著。对于血浆亚硝酸盐,仅在α1组(r = -0.673,P =.016)和α2组(r = -0.643,P =.024)中观察到显著相关性。只有α2组在NOS活性和亚硝酸盐水平之间显示出显著的正相关(r = 0.777,P =.003)。总之,发现与WKY大鼠相比,SHR血管中的NOS活性较低,但用抗氧化剂α-生育酚治疗后,NOS活性增加,同时血压降低。血管中的脂质过氧化物与NOS和一氧化氮存在相关性,这意味着自由基可能参与高血压的发病机制。